Dott. Luigi Vicari on gennaio 15th, 2009

Se il medico nel corso di un intervento si trova a effettuare un’operazione necessaria e urgente, ma non concordata preventivamente con il paziente e, quindi, privo del consenso firmato, non commette reato di violenza privata. Con una pronuncia della Suprema Corte riunita a Sezioni unite penali, lo scorso 18 dicembre, si rimette in primo piano [...]

Continue reading about Cassazione: vacilla il consenso informato

Dott. Luigi Vicari on gennaio 11th, 2009

In tema di accesso agli atti amministrativi, qualora una Pubblica amministrazione detenga un documento amministrativo la cui conoscenza sia in grado di soddisfare la posizione giuridicamente protetta di un determinato soggetto, nel senso che esiste un rapporto di strumentalità tra la conoscenza del documento (mezzo per la difesa degli interessi) ed il fine (effettiva tutela [...]

Continue reading about TAR PUGLIA: Legittimità del diritto di accesso ai titoli di studio

Dott. Luigi Vicari on gennaio 10th, 2009

Researchers at Oregon Health & Science University’s School of Dentistry (http://www.ohsu.edu/sod) have discovered a novel function of the peptide known as Nerve Growth Factor (NGF) in the development of the trigeminal nerve. The trigeminal nerve provides the signaling pathway for periodontal pain, dental surgical pain, and pain associated with temporomandibular disorder, trigeminal neuralgia, migraine, and [...]

Continue reading about Mechanism For Dental Pain Uncovered By OHSU School Of Dentistry

The spread of cancer to the bones (called bone metastases) is one of the most frequent causes of severe pain in people with cancer. While drugs, radiation therapy and surgery sometimes help reduce the pain, a common technology may offer a new approach. It’s called MRI-guided focused ultrasound, used by a device named ExAblate.

Continue reading about Fox Chase Studies Ultrasound To Relieve Severe Pain Of Cancer In The Bones

Dott. Luigi Vicari on gennaio 10th, 2009

AIOM (09/2009): Gestione della Tossicità Ematopoietica in Oncologia National Comprehensive Cancer Network (2009): Cancer- and Chemotherapy-Induced Anemia

Continue reading about Anemia

Dott. Luigi Vicari on gennaio 7th, 2009

by Teri Robert, Lead Expert In learning about Migraines and headaches, we’ve learned that taking some medications more than two or three days a week can lead to medication overuse headache, aka rebound. We’ve also learned that medication overuse is a factor in 80% of cases of transformed Migraine. Now, there’s additional evidence that any [...]

Continue reading about Transformed Migraine – Risk Increased by Some Medications

Dott. Luigi Vicari on gennaio 7th, 2009

Dal 1° gennaio 2009 la versione cartacea non viene più stampata. L’arrivo del 2009 ha portato con sé la fine della pubblicazione cartacea della Gazzetta Ufficiale della Repubblica Italiana: dal primo gennaio è disponibile solo in formato elettronico. L’ultimo numero della versione “fisica”, in edicola il 31 dicembre, ricordava che con il nuovo anno la [...]

Continue reading about La Gazzetta Ufficiale è solo online

Dott. Luigi Vicari on gennaio 7th, 2009

Prof Tamás Paál, Hungary (Signal Reviewer for the WHO-UMC Programme for International Drug Monitoring) Drotrecogin alfa (activated) is a recombinant form of human activated protein C that has anti-thrombotic, anti-inflammatory and profibrinolytic activities. It is used mainly in intensive care medicine as a treatment for severe sepsis (sepsis associated with acute organ dysfunction). It is [...]

Continue reading about Drotrecogin alfa – Thrombosis?

Dott. Luigi Vicari on gennaio 7th, 2009

UK. The Commission on Human Medicines has said that there is no strong evidence that paracetamol use in infancy can cause asthma. This follows a review of a study published in the Lancet that explored the link between paracetamol use in infancy and the risk of asthma, rhinoconjunctivitis, and eczema in children aged six/seven years. [...]

Continue reading about Paracetamol: Debate on paracetamol-asthma link

Europe. The EMEA has recommended the suspension of the marketing authorization of a system (Ionsys) for the transdermal delivery of fentanyl, an opioid analgesic. This drug delivery system marketed by Janssen-Cilag International NV, has a defect that could lead to patients being overdosed. It has been authorized in the European Union (EU) since January 2006 [...]

Continue reading about Fentanyl transdermal delivery system: Defect in device leads to suspension

The most common way of managing the pain that accompanies inflammation is to use drugs such as aspirin and ibuprofen. These work by selectively blocking the protein COX2, which functions to produce soluble molecules known as prostaglandins.

Continue reading about Pain Caused By Physical Insult Sensed By Nerve Cells In The Brain And Spinal Cord

Minimal Criteria 1.  A compelling urge to move the limbs, usually associated with paresthesias or dysesthesias 2.  Motor restlessness as seen in activities such as floor pacing, tossing and turning in bed and rubbing the legs 3.  Symptoms that are worse or present only during rest and are partially or temporarily relieved by activity 4.  [...]

Continue reading about Diagnostic Criteria and Associated Features of Restless Legs Syndrome (RLS)

Dott. Luigi Vicari on gennaio 7th, 2009

The word dermatome refers to a correspondence between the skin and the nervous system.  Sensory dermatome maps used to help localize the level of neurologic deficit.

Continue reading about Mappa dei Dermatomeri Sensitivi (Sensory Dermatome Maps)

Abstral® is an important new treatment option for inadequately controlled breakthrough cancer pain (BTcP) in opioid-tolerant cancer patients. The Abstral formulation delivers the analgesic power of fentanyl in a fast dissolving sublingual tablet. Abstral provides rapid relief of BTcP from 10 minutes1, provides predictable dosing2,3 and is convenient and easy to use.

Continue reading about Introducing Abstral(R). Innovative Drug Delivery Technology For Rapid Breakthrough Cancer Pain Management

Dott. Luigi Vicari on gennaio 4th, 2009

Convincing evidence to recommend antioxidants for treatment has been  lacking  Bethesda, MD (Jan. 1, 2009) Antioxidant supplementation was found to be effective in relieving pain and reducing levels of oxidative stress in patients with chronic pancreatitis (CP), reports a new study in Gastroenterology.

Continue reading about Antioxidants offer pain relief in patients with chronic pancreatitis